Literature DB >> 17655812

Costs of needlestick injuries and subsequent hepatitis and HIV infection.

J Paul Leigh1, Marion Gillen, Peter Franks, Susan Sutherland, Hienh H Nguyen, Kyle Steenland, Guibo Xing.   

Abstract

BACKGROUND: Physicians, nurses and other healthcare workers (HCWs) are at risk of bloodborne pathogens infection from needlestick injuries, but costs of needlesticks are little studied.
METHODS: We used the cost-of-illness and incidence approaches. We used the perspective of the medical provider (medical costs) and the individual (lost productivity). Data on needlesticks, infections from hepatitis B and C (HBV, HCV) and human immune-deficiency (HIV) among HCWs, as well as data on per-unit costs were culled from research literature, Centers for Disease Control and Prevention reports, and Bureau of Labor Statistics reports. We also generated estimates based upon industry employment and scenarios for source-patients. These data and estimates were combined with assumptions to produce a model that generated base-case estimates as well as one-way and multi-way probabilistic sensitivity analyses. Future costs were discounted by 3%.
RESULTS: We estimated 644,963 needlesticks in the healthcare industry for 2004 of which 49% generated costs. Medical costs were $107.3 million of which 96% resulted from testing and prophylaxis and 4% from treating long-term infections (34 persons with chronic HBV, 143 with chronic HCV, and 1 with HIV). Lost-work productivity generated $81.2 million, for which 59% involved testing and prophylaxis and 41% involved long-term infections. Combined medical and work productivity costs summed to $188.5 million. Multi-way sensitivity analysis suggested a range on combined costs from $100.7 million to $405.9 million.
CONCLUSION: Detailed methodology was developed to estimate costs of needlesticks and subsequent infections for hospital-based and non-hospital-based health care workers. The combined medical and lost productivity costs comprised roughly 0.1% of all occupational injury and illness costs for all jobs in the economy. We did not account for lost home production or pain and suffering costs, however, nor did we estimate benefit/cost ratios of specific interventions to reduce needlesticks.

Entities:  

Mesh:

Year:  2007        PMID: 17655812     DOI: 10.1185/030079907X219517

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  8 in total

1.  Use of safety syringes for administration of local anaesthesia among a sample of UK primary care dental professionals.

Authors:  K Trayner; M Nguyen; L Hopps; M Christie; K Roy; J Bagg
Journal:  Br Dent J       Date:  2018-11-23       Impact factor: 1.626

Review 2.  Needlestick injuries in veterinary medicine.

Authors:  J Scott Weese; Douglas C Jack
Journal:  Can Vet J       Date:  2008-08       Impact factor: 1.008

Review 3.  Devices for preventing percutaneous exposure injuries caused by needles in healthcare personnel.

Authors:  Viraj K Reddy; Marie-Claude Lavoie; Jos H Verbeek; Manisha Pahwa
Journal:  Cochrane Database Syst Rev       Date:  2017-11-14

4.  Behavior of healthcare workers after injuries from sharp instruments.

Authors:  Mohsen Adib-Hajbaghery; Mohammad Sajjad Lotfi
Journal:  Trauma Mon       Date:  2013-08-14

Review 5.  Clinical, economic, and humanistic burden of needlestick injuries in healthcare workers.

Authors:  Catherine E Cooke; Jennifer M Stephens
Journal:  Med Devices (Auckl)       Date:  2017-09-29

6.  Post-vaccination anti-HBs testing among healthcare workers: More economical than post-exposure management for Hepatitis B.

Authors:  Camila Lucas de Souza; Thaís de Arvelos Salgado; Tatiana Luciano Sardeiro; Hélio Galdino Junior; Alexander Itria; Anaclara Ferreira Veiga Tipple
Journal:  Rev Lat Am Enfermagem       Date:  2020-06-19

Review 7.  How Much do Needlestick Injuries Cost? A Systematic Review of the Economic Evaluations of Needlestick and Sharps Injuries Among Healthcare Personnel.

Authors:  Alice Mannocci; Gabriella De Carli; Virginia Di Bari; Rosella Saulle; Brigid Unim; Nicola Nicolotti; Lorenzo Carbonari; Vincenzo Puro; Giuseppe La Torre
Journal:  Infect Control Hosp Epidemiol       Date:  2016-03-29       Impact factor: 3.254

8.  Preventing hepatitis B virus infection among healthcare professionals: potential impact of a 2-dose versus 3-dose vaccine.

Authors:  Catherine Stevenson; Ji-Hee Youn; Mary S Hayney; Coline David
Journal:  Hum Vaccin Immunother       Date:  2021-09-10       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.